EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of glutathione peroxidase-1 immunoreactive cells in pancreatic islets from type 1 diabetic donors and non-diabetic donors with and without islet cell autoantibodies is variable and independent of disease

Kaaj Pala, Kevin Xueying Sun, Lars Krogvold, Knut Dahl-Jørgensen, Shiva Reddy

Cell and Tissue Research · 2025-06 · 400 (3) · 255-271

DOI: 10.1007/s00441-025-03955-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Tissue Research, online erschienen am 10.03.2025. Verfasst von Kaaj Pala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1023, New Zealand. Hauptthemen laut MEDLINE: Glutathione Peroxidase, Diabetes Mellitus, Type 1, Autoantibodies, Islets of Langerhans. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Maurice Phyllis Paykel Trust of New Zealand, the European Union's Seventh Framework Programme, the European Union’s Seventh Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During type 1 diabetes (T1D), oxidative stress in beta cells may cause early beta cell dysfunction and initiate autoimmunity. Mouse islets express lower levels of reactive oxygen species (ROS) clearing enzymes, such as glutathione peroxidase (GPX), superoxide dismutase (SOD) and catalase than several other tissues. It remains unclear if human beta cells show a similar deficiency during T1D or exhibit a higher degree of intrinsic resistance to oxidative stress. We compared islet cell distributions and determined graded intensities of glutathione peroxidase1 (GPX1), a key enzymatic mediator involved in detoxifying hydrogen peroxide, by applying combined immunohistochemistry for GPX1, insulin and glucagon, in pancreatic sections from new-onset T1D (group 1), non-diabetic autoantibody-negative (group 2), non-diabetic autoantibody-positive (group 3) and long-term diabetic (group 4) donors. Islets from all study groups demonstrated either uniform but graded staining intensities for GPX1 in almost all islet cells or strong staining in selective islet cells with weaker intensities in the remaining cells. GPX1 was present in selective glucagon cells and insulin cells, including in cells negative for both hormones, with stronger intensities in a higher percentage of glucagon than insulin cells. It was absent in a higher percentage of beta cells than glucagon cells independent of disease or autoantibody positivity. We conclude that a proportion of human beta cells and glucagon cells express GPX1 but show heterogeneity in its distribution and intensities, independent of disease or autoantibody status. Our studies highlight important differences in the expression of GPX1 in islet cell-types between mice and humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutathione PeroxidaseDiabetes Mellitus, Type 1AutoantibodiesIslets of LangerhansTissue DonorsHumansGlutathione Peroxidase GPX1FemaleMaleAdultMiddle AgedGlucagonAdolescentAnimalsImmunohistochemistryInsulin

Stichwörter der Autor:innen

Beta cell damageGlutathione peroxidase-1ImmunohistochemistryReactive oxygen speciesType 1 diabetes

Substanzen

Glutathione PeroxidaseAutoantibodiesGlutathione Peroxidase GPX1GPX1 protein, humanGlucagonInsulin

Autor:innen und Institutionen

  • Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1023, New Zealand.
  • Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Faculty of Dentistry, University of Oslo, Oslo, Norway.
  • Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Oslo University Hospital, Oslo, Norway.
  • Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1023, New Zealand. s.reddy@auckland.ac.nz.

Förderung

  • the Maurice Phyllis Paykel Trust of New Zealand
  • the European Union's Seventh Framework Programme
  • the European Union’s Seventh Framework Programme
  • South Eastern Norway Regional Health Authority
  • University of Auckland

Zitieren

APA

Pala, K., Sun, K. X., Krogvold, L., Dahl-Jørgensen, K., & Reddy, S. (2025). Distribution of glutathione peroxidase-1 immunoreactive cells in pancreatic islets from type 1 diabetic donors and non-diabetic donors with and without islet cell autoantibodies is variable and independent of disease. Cell and Tissue Research, 400(3), 255-271. https://doi.org/10.1007/s00441-025-03955-5

Vancouver

Pala K, Sun KX, Krogvold L, Dahl-Jørgensen K, Reddy S. Distribution of glutathione peroxidase-1 immunoreactive cells in pancreatic islets from type 1 diabetic donors and non-diabetic donors with and without islet cell autoantibodies is variable and independent of disease. Cell and Tissue Research. 2025;400(3):255-271. doi:10.1007/s00441-025-03955-5

BibTeX
@article{Pala2025,
  author = {Pala, Kaaj and Sun, Kevin Xueying and Krogvold, Lars and Dahl-Jørgensen, Knut and Reddy, Shiva},
  title = {Distribution of glutathione peroxidase-1 immunoreactive cells in pancreatic islets from type 1 diabetic donors and non-diabetic donors with and without islet cell autoantibodies is variable and independent of disease},
  journal = {Cell and Tissue Research},
  year = {2025},
  volume = {400},
  number = {3},
  pages = {255--271},
  doi = {10.1007/s00441-025-03955-5}
}
Kostenlos starten →